News
Media
Conferences
Publications
CME/CE
Resources
Subscribe
About
Partnerships

|Articles|April 15, 2002

Charles J. Lockwood, MD, answers questions on antiphospholipid antibodies (APAs)

Newsletter

Get the latest clinical updates, case studies, and expert commentary in obstetric and gynecologic care. Sign up now to stay informed.

Related Content

Recognizing signs of postpartum psychosis, with Alexis Totaro, MSN

Recognizing signs of postpartum psychosis, with Alexis Totaro, MSN

ByAlexis Totaro, MSN, RN, WHNP-c, CARN-AP

August 25th 2026

Report: Postpartum depression market expected to grow based on awareness, pipeline progress

Report: Postpartum depression market expected to grow based on awareness, pipeline progress

ByJoshua Fitch, Senior Editor

August 25th 2026

Early-onset severe HDP carries highest recurrence risk, study finds

Early-onset severe HDP carries highest recurrence risk, study finds

ByJoshua Fitch, Senior Editor

August 24th 2026

Study details cesarean use in life-limiting fetal diagnosis cases | image credit: stock.adobe.com

Study details cesarean use in life-limiting fetal diagnosis cases

ByJoshua Fitch, Senior Editor

August 24th 2026

FDA-cleared vaginal device launches, asthma control as fetal protection, IVF's bladder symptom cues

FDA-cleared vaginal device launches, asthma control as fetal protection, IVF's bladder symptom cues

ByJoshua Fitch, Senior Editor

August 21st 2026

Latest CME

Join Us at The Pathology Meeting in Las Vegas

In-Person + Virtual Event

Join Us at The Pathology Meeting in Las Vegas

October 5, 2026

Trending on Contemporary OB/GYN

Study details cesarean use in life-limiting fetal diagnosis cases

Recognizing signs of postpartum psychosis, with Alexis Totaro, MSN

Report: Postpartum depression market expected to grow based on awareness, pipeline progress

Early-onset severe HDP carries highest recurrence risk, study finds

FDA-cleared vaginal device launches, asthma control as fetal protection, IVF's bladder symptom cues